2-108768392-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_006267.5(RANBP2):​c.7849+4A>G variant causes a splice region, intron change. The variant allele was found at a frequency of 0.00469 in 1,599,878 control chromosomes in the GnomAD database, including 116 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0058 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0046 ( 111 hom. )

Consequence

RANBP2
NM_006267.5 splice_region, intron

Scores

2
Splicing: ADA: 0.03582
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 3.98

Publications

4 publications found
Variant links:
Genes affected
RANBP2 (HGNC:9848): (RAN binding protein 2) RAN is a small GTP-binding protein of the RAS superfamily that is associated with the nuclear membrane and is thought to control a variety of cellular functions through its interactions with other proteins. This gene encodes a very large RAN-binding protein that immunolocalizes to the nuclear pore complex. The protein is a giant scaffold and mosaic cyclophilin-related nucleoporin implicated in the Ran-GTPase cycle. The encoded protein directly interacts with the E2 enzyme UBC9 and strongly enhances SUMO1 transfer from UBC9 to the SUMO1 target SP100. These findings place sumoylation at the cytoplasmic filaments of the nuclear pore complex and suggest that, for some substrates, modification and nuclear import are linked events. This gene is partially duplicated in a gene cluster that lies in a hot spot for recombination on chromosome 2q. [provided by RefSeq, Jul 2008]
RANBP2 Gene-Disease associations (from GenCC):
  • familial acute necrotizing encephalopathy
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Leigh syndrome
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 2-108768392-A-G is Benign according to our data. Variant chr2-108768392-A-G is described in ClinVar as Benign. ClinVar VariationId is 382464.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00582 (886/152106) while in subpopulation SAS AF = 0.0211 (102/4832). AF 95% confidence interval is 0.0178. There are 5 homozygotes in GnomAd4. There are 450 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 886 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RANBP2NM_006267.5 linkc.7849+4A>G splice_region_variant, intron_variant Intron 20 of 28 ENST00000283195.11 NP_006258.3 P49792

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RANBP2ENST00000283195.11 linkc.7849+4A>G splice_region_variant, intron_variant Intron 20 of 28 1 NM_006267.5 ENSP00000283195.6 P49792

Frequencies

GnomAD3 genomes
AF:
0.00582
AC:
885
AN:
151988
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00150
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00596
Gnomad ASJ
AF:
0.00837
Gnomad EAS
AF:
0.0202
Gnomad SAS
AF:
0.0209
Gnomad FIN
AF:
0.000470
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00685
Gnomad OTH
AF:
0.0120
GnomAD2 exomes
AF:
0.00479
AC:
1169
AN:
243906
AF XY:
0.00465
show subpopulations
Gnomad AFR exome
AF:
0.00130
Gnomad AMR exome
AF:
0.00259
Gnomad ASJ exome
AF:
0.00345
Gnomad EAS exome
AF:
0.0159
Gnomad FIN exome
AF:
0.000238
Gnomad NFE exome
AF:
0.00353
Gnomad OTH exome
AF:
0.00686
GnomAD4 exome
AF:
0.00457
AC:
6620
AN:
1447772
Hom.:
111
Cov.:
33
AF XY:
0.00488
AC XY:
3512
AN XY:
720314
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000719
AC:
24
AN:
33368
American (AMR)
AF:
0.00267
AC:
119
AN:
44496
Ashkenazi Jewish (ASJ)
AF:
0.00516
AC:
134
AN:
25972
East Asian (EAS)
AF:
0.0301
AC:
1181
AN:
39300
South Asian (SAS)
AF:
0.0144
AC:
1227
AN:
85188
European-Finnish (FIN)
AF:
0.000648
AC:
34
AN:
52466
Middle Eastern (MID)
AF:
0.00316
AC:
13
AN:
4116
European-Non Finnish (NFE)
AF:
0.00327
AC:
3611
AN:
1103038
Other (OTH)
AF:
0.00463
AC:
277
AN:
59828
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.380
Heterozygous variant carriers
0
367
734
1102
1469
1836
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
128
256
384
512
640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00582
AC:
886
AN:
152106
Hom.:
5
Cov.:
32
AF XY:
0.00605
AC XY:
450
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.00149
AC:
62
AN:
41560
American (AMR)
AF:
0.00595
AC:
91
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00837
AC:
29
AN:
3466
East Asian (EAS)
AF:
0.0202
AC:
105
AN:
5186
South Asian (SAS)
AF:
0.0211
AC:
102
AN:
4832
European-Finnish (FIN)
AF:
0.000470
AC:
5
AN:
10630
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00686
AC:
465
AN:
67828
Other (OTH)
AF:
0.0119
AC:
25
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.446
Heterozygous variant carriers
0
35
70
105
140
175
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00661
Hom.:
3
Bravo
AF:
0.00662

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Benign:1
Mar 22, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Familial acute necrotizing encephalopathy Benign:1
Oct 29, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.49
CADD
Benign
17
DANN
Benign
0.70
PhyloP100
4.0
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.036
dbscSNV1_RF
Benign
0.41
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2949961; hg19: chr2-109384848; COSMIC: COSV51696919; API